atherosclerosis, hypercholesterolemia, cancer, naive T-cell exhaustion, HIV non-responders
drugs, small molecule
Repair Biotechnologies is a longevity company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself.
Founded in 2018 by Reason and Bill Cherman, Repair Biotechnologies is developing therapies with the goals of reversing atherosclerosis and atrophy of the thymus. As the first company accepted to Ichor Therapeutics’ Grapeseed.bio incubator, Repair Biotechnologies is based in Lafayette, NY.